A 32-year-old woman from Chennai presents on day 4 of fever with severe myalgia, headache, and a maculopapular rash over trunk and extremities. She has thrombocytopenia (platelets 80,000/μL) and haemoconcentration. Which investigation is most appropriate to confirm dengue virus infection at this stage?

Explanation

## Dengue Diagnosis by Stage of Illness **Key Point:** The choice of diagnostic test for dengue depends critically on the day of illness. On **day 4**, NS1 antigen detection remains highly sensitive and is the most appropriate investigation to **confirm dengue virus infection**. ### Timing of Dengue Diagnostic Tests | Investigation | Day 1–5 (Febrile Phase) | Day 5–7 (Defervescence) | Day 7+ (Convalescent) | | --- | --- | --- | --- | | **NS1 antigen** | Highly sensitive (>90%) | Declining sensitivity | Negative | | **Dengue IgM** | Begins to appear day 3–5 | Peak sensitivity (>95%) | Persists 3–6 months | | **Dengue IgG** | Absent or weak (primary) | Begins to appear | Strong, persists years | | **Viral culture** | Possible but slow (days–weeks) | Not practical | Not useful | **High-Yield:** NS1 (Non-Structural Protein 1) is a viral antigen secreted into the bloodstream during active dengue virus replication. It is detectable from **day 1 through day 5–6** of illness with sensitivity >90%. On day 4, the patient is still in the febrile/early defervescence phase, and NS1 antigen ELISA is the **most sensitive and specific direct virological marker** available at this stage. **Clinical Pearl:** IgM antibodies begin to appear around day 3–5 but reach peak sensitivity only by day 5–7. On day 4, IgM may still be absent or at sub-detectable levels in a significant proportion of patients, making NS1 antigen the superior choice for **confirmation** at this time point. IgM ELISA becomes the preferred test from day 5–7 onwards. ### Why NS1 Antigen ELISA Is Correct Here 1. **Timing:** Day 4 falls squarely within the NS1 detection window (days 1–5/6). Sensitivity remains >90% at this stage (WHO Dengue Guidelines, 2009; Park's Textbook of Preventive and Social Medicine). 2. **Direct confirmation:** NS1 detects viral antigen directly, confirming active infection — it is not an indirect serological marker. 3. **IgM limitation:** IgM is still emerging on day 4 and may be negative in up to 30–40% of patients at this stage, making it less reliable for confirmation. 4. **IgG:** Absent in primary infection at day 4; only rises in secondary infection — not useful for confirmation. 5. **Viral culture:** Takes days to weeks, is technically demanding, and is not a practical confirmatory test. **Mnemonic: "NS1 EARLY, IgM LATER"** - **Days 1–5:** NS1 antigen (direct, most sensitive for confirmation) - **Days 5–14:** IgM ELISA (peak sensitivity, preferred in late acute/convalescent) - **Days 7+:** IgG (secondary infection marker, persists years) *Reference: WHO Dengue Guidelines for Diagnosis, Treatment, Prevention and Control (2009); Park's Textbook of Preventive and Social Medicine, 27th edition.*